Literature DB >> 15998220

Myocardial engineering in vivo: formation and characterization of contractile, vascularized three-dimensional cardiac tissue.

Ravi K Birla1, Gregory H Borschel, Robert G Dennis, David L Brown.   

Abstract

Engineering cardiac tissue in three dimensions is limited by the ability to supply nourishment to the cells in the center of the construct. This limits the radius of an in vitro engineered cardiac construct to approximately 40 microm. This study describes a method of engineering contractile three-dimensional cardiac tissue with the incorporation of an intrinsic vascular supply. Neonatal cardiac myocytes were cultured in vivo in silicone chambers, in close proximity to an intact vascular pedicle. Silicone tubes were filled with a suspension of cardiac myocytes in fibrin gel and surgically placed around the femoral artery and vein of adult rats. At 3 weeks, the tissues in the chambers were harvested for in vitro contractility evaluation and processed for histologic analysis. By 3 weeks, the chambers had become filled with living tissue. Hematoxylin and eosin staining showed large amounts of muscle tissue situated around the femoral vessels. Electron micrographs revealed well-organized intracellular contractile machinery and a high degree of intercellular connectivity. Immunostaining for von Willebrand factor demonstrated neovascularization throughout the constructs. With electrical stimulation, the constructs were able to generate an average active force of 263 microN with a maximum of 843 microN. Electrical pacing was successful at frequencies of 1 to 20 Hz. In addition, the constructs exhibited positive inotropy in response to ionic calcium and positive chronotropy in response to epinephrine. As engineering of cardiac replacement tissue proceeds, vascularization is an increasingly important component in the development of three-dimensional structures. This study demonstrates the in vivo survival, vascularization, organization, and functionality of transplanted myocardial cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15998220     DOI: 10.1089/ten.2005.11.803

Source DB:  PubMed          Journal:  Tissue Eng        ISSN: 1076-3279


  30 in total

Review 1.  Getting to the heart of tissue engineering.

Authors:  Luda Khait; Louise Hecker; Nicole R Blan; Garrett Coyan; Francesco Migneco; Yen-Chih Huang; Ravi K Birla
Journal:  J Cardiovasc Transl Res       Date:  2008-01-29       Impact factor: 4.132

2.  A bilayer construct controls adipose-derived stem cell differentiation into endothelial cells and pericytes without growth factor stimulation.

Authors:  Shanmugasundaram Natesan; Ge Zhang; David G Baer; Thomas J Walters; Robert J Christy; Laura J Suggs
Journal:  Tissue Eng Part A       Date:  2011-01-04       Impact factor: 3.845

Review 3.  Strategies for tissue engineering cardiac constructs to affect functional repair following myocardial infarction.

Authors:  Kathy Yuan Ye; Lauren Deems Black
Journal:  J Cardiovasc Transl Res       Date:  2011-08-05       Impact factor: 4.132

4.  Three-dimensional culture alters primary cardiac cell phenotype.

Authors:  Robert E Akins; Danielle Rockwood; Karyn G Robinson; Daniel Sandusky; John Rabolt; Christian Pizarro
Journal:  Tissue Eng Part A       Date:  2010-02       Impact factor: 3.845

Review 5.  Biomaterials to prevascularize engineered tissues.

Authors:  Lei Tian; Steven C George
Journal:  J Cardiovasc Transl Res       Date:  2011-09-03       Impact factor: 4.132

Review 6.  Myocardial tissue engineering: in vitro models.

Authors:  Gordana Vunjak Novakovic; Thomas Eschenhagen; Christine Mummery
Journal:  Cold Spring Harb Perspect Med       Date:  2014-03-01       Impact factor: 6.915

7.  Use of myocardial matrix in a chitosan-based full-thickness heart patch.

Authors:  Seokwon Pok; Omar M Benavides; Patrick Hallal; Jeffrey G Jacot
Journal:  Tissue Eng Part A       Date:  2014-02-24       Impact factor: 3.845

Review 8.  Heart regeneration with engineered myocardial tissue.

Authors:  Kareen L K Coulombe; Vivek K Bajpai; Stelios T Andreadis; Charles E Murry
Journal:  Annu Rev Biomed Eng       Date:  2014-04-24       Impact factor: 9.590

9.  Effect of streptomycin on the active force of bioengineered heart muscle in response to controlled stretch.

Authors:  R K Birla; Y C Huang; R G Dennis
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-06-21       Impact factor: 2.416

10.  Development of a Cyclic Strain Bioreactor for Mechanical Enhancement and Assessment of Bioengineered Myocardial Constructs.

Authors:  Betsy H Salazar; Avery T Cashion; Robert G Dennis; Ravi K Birla
Journal:  Cardiovasc Eng Technol       Date:  2015-07-24       Impact factor: 2.495

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.